
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer
Zhucheng Zhao, Yanmao Wang, Yuyan Gong, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Zhucheng Zhao, Yanmao Wang, Yuyan Gong, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies
Fahad Khan, Pratibha Pandey, Meenakshi Verma, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 200-200
Open Access | Times Cited: 10
Fahad Khan, Pratibha Pandey, Meenakshi Verma, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 200-200
Open Access | Times Cited: 10
Biomimetic celastrol nanocrystals with enhanced efficacy and reduced toxicity for suppressing breast cancer invasion and metastasis
Shuang Du, Kui Wu, Yucheng Guan, et al.
International Journal of Pharmaceutics (2025) Vol. 671, pp. 125221-125221
Closed Access
Shuang Du, Kui Wu, Yucheng Guan, et al.
International Journal of Pharmaceutics (2025) Vol. 671, pp. 125221-125221
Closed Access
SRF/SLC31A1 signaling promotes cuproptosis induced by celastrol in NSCLC
Rui Xue, Chuling Qin, Lanyu Li, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114165-114165
Closed Access
Rui Xue, Chuling Qin, Lanyu Li, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114165-114165
Closed Access
Dihydrotanshinone I potentiates the anti-tumor activity of cisplatin by activating ROS-mediated ER stress through targeting HSPD1 in lung cancer cells
Haizhen Lin, Hehuan Sui, Ying Yu, et al.
European Journal of Pharmacology (2025) Vol. 994, pp. 177378-177378
Closed Access
Haizhen Lin, Hehuan Sui, Ying Yu, et al.
European Journal of Pharmacology (2025) Vol. 994, pp. 177378-177378
Closed Access
Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer
Jingyi Huang, Jingbin Shi, Ninghui Ma, et al.
Phytomedicine (2025) Vol. 139, pp. 156514-156514
Closed Access
Jingyi Huang, Jingbin Shi, Ninghui Ma, et al.
Phytomedicine (2025) Vol. 139, pp. 156514-156514
Closed Access
Celastrol promotes apoptotic cell death in thyroid cancer cells through a caspases-dependent pathway
Ruoyi Yang, Jie Yao, Hong Ma, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Ruoyi Yang, Jie Yao, Hong Ma, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Construction of dual-targeted liposomes loaded with celastrol and their application in treating intrahepatic cholangiocarcinoma
Jun Tang, Yimeng Yang, Zihan He, et al.
Materials Today Bio (2025) Vol. 31, pp. 101581-101581
Open Access
Jun Tang, Yimeng Yang, Zihan He, et al.
Materials Today Bio (2025) Vol. 31, pp. 101581-101581
Open Access
Natural Product-Empowered Green Strategy for Colorimetric Detection of Hydrogen Sulfide
Rongxian Bai, Shufan Wan, Limei Zhao, et al.
Analytical Chemistry (2025)
Closed Access
Rongxian Bai, Shufan Wan, Limei Zhao, et al.
Analytical Chemistry (2025)
Closed Access
Computational identification of potential natural terpenoid inhibitors of MDM2 for breast cancer therapy: molecular docking, molecular dynamics simulation, and ADMET analysis
Eva Azme, Md. Mahmudul Hasan, Md. Liakot Ali, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Eva Azme, Md. Mahmudul Hasan, Md. Liakot Ali, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
An Inhaled Nanoemulsion Encapsulating a Herbal Drug for Non-Small Cell Lung Cancer (NSCLC) Treatment
Mural Quadros, Mimansa Goyal, Gautam Chauhan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 540-540
Open Access
Mural Quadros, Mimansa Goyal, Gautam Chauhan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 540-540
Open Access
Arjunolic acid from Rhodomyrtus tomentosa Suppresses Growth of Non-Small Cell Lung Cancer via Inducing Autophagy and Apoptosis
Ziying Huang, Chang Liu, Chenchen Zhang, et al.
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100616-100616
Open Access
Ziying Huang, Chang Liu, Chenchen Zhang, et al.
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100616-100616
Open Access
MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma
Longxiyu Meng, Jie Gao, Wenjing Mo, et al.
Redox Biology (2023) Vol. 68, pp. 102956-102956
Open Access | Times Cited: 10
Longxiyu Meng, Jie Gao, Wenjing Mo, et al.
Redox Biology (2023) Vol. 68, pp. 102956-102956
Open Access | Times Cited: 10
Mebendazole induces apoptosis and inhibits migration via the reactive oxygen species-mediated STAT3 signaling downregulation in non-small cell lung cancer
Zhipan Liang, Qiu‐Yun Chen, Liuying Pan, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 1412-1423
Open Access | Times Cited: 3
Zhipan Liang, Qiu‐Yun Chen, Liuying Pan, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 2, pp. 1412-1423
Open Access | Times Cited: 3
Visible light accelerates skin wound healing and alleviates scar formation in mice by adjusting STAT3 signaling
Fangqing Deng, Yang Rong, Yingchun Yang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Fangqing Deng, Yang Rong, Yingchun Yang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Discovery of cinnamylaldehyde-derived mono-carbonyl curcumin analogs as anti-gastric cancer agents via suppression of STAT3 and AKT pathway
Xi Chen, Peiqin Zhang, Huating Zhang, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107306-107306
Closed Access | Times Cited: 2
Xi Chen, Peiqin Zhang, Huating Zhang, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107306-107306
Closed Access | Times Cited: 2
Recent Trends in anti-tumor mechanisms and molecular targets of celastrol
Yongping Zhu, Yuqing Meng, Junzhe Zhang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 14, pp. 5510-5530
Open Access | Times Cited: 2
Yongping Zhu, Yuqing Meng, Junzhe Zhang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 14, pp. 5510-5530
Open Access | Times Cited: 2
Druggability, molecular targets, and nanocarrier delivery of natural triterpenoid celastrol against chronic diseases
Chi Lui Chan, Yilu Sun, Xiaowen Mao, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 2
Chi Lui Chan, Yilu Sun, Xiaowen Mao, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 2
Piperlongumine is a ligand for the orphan nuclear receptor 4A1 (NR4A1)
Lei Zhang, Greg Martin, Kumaravel Mohankumar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Lei Zhang, Greg Martin, Kumaravel Mohankumar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Wei Hu, Chongfei Zhao, Rongkun Zheng, et al.
Pest Management Science (2023)
Open Access | Times Cited: 4
Celastrol induces premature ovarian insufficiency by inducing apoptosis in granulosa cells
Wen Fan, Dandan Liu, Mingming Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115815-115815
Open Access | Times Cited: 4
Wen Fan, Dandan Liu, Mingming Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115815-115815
Open Access | Times Cited: 4
Celastrol, which targets IL-2/CD25 binding inhibition, induces T cell-mediated antitumor activity in melanoma
Okki Cho, Joong-Woon Lee, Youngjin Jeong, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176239-176239
Closed Access | Times Cited: 4
Okki Cho, Joong-Woon Lee, Youngjin Jeong, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176239-176239
Closed Access | Times Cited: 4
Altered Iron-Mediated Metabolic Homeostasis Governs the Efficacy and Toxicity of Tripterygium Glycosides Tablets Against Rheumatoid Arthritis
Zihe Ding, Xiaoyue Wang, Yi Zhang, et al.
Engineering (2024) Vol. 39, pp. 166-179
Open Access | Times Cited: 1
Zihe Ding, Xiaoyue Wang, Yi Zhang, et al.
Engineering (2024) Vol. 39, pp. 166-179
Open Access | Times Cited: 1
Green synthesis of gold nanoparticles by celastrol for chemotherapy and photothermal anticancer therapy
Yifan Bo, Yinchuan Wang, Yuan Liu, et al.
Materials Open (2024) Vol. 02
Closed Access | Times Cited: 1
Yifan Bo, Yinchuan Wang, Yuan Liu, et al.
Materials Open (2024) Vol. 02
Closed Access | Times Cited: 1
Novel Strategies for Tumor Treatment: Harnessing ROS-Inducing Active Ingredients from Traditional Chinese Medicine Through Multifunctional Nanoformulations
Zhengguang Zhang, M. Y. Li, Xiaolong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9659-9688
Open Access | Times Cited: 1
Zhengguang Zhang, M. Y. Li, Xiaolong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9659-9688
Open Access | Times Cited: 1
ML385, an Nrf2 Inhibitor, Synergically Enhanced Celastrol Triggered Endoplasmic Reticulum Stress in Lung Cancer Cells
Chenxin Xu, Yinghua Chen, Zhenhuan Zhou, et al.
ACS Omega (2024) Vol. 9, Iss. 43, pp. 43697-43705
Open Access | Times Cited: 1
Chenxin Xu, Yinghua Chen, Zhenhuan Zhou, et al.
ACS Omega (2024) Vol. 9, Iss. 43, pp. 43697-43705
Open Access | Times Cited: 1